menu
    • menu

    Company profile for RhoVac AB

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    RhoVac® is a pharmaceutical company dedicated to immuno-oncology, signifying that the body’s own immune system is stimulated to identify and destroy cancer cells. The primary focus of RhoVac® is to develop a cancer therapy that targets metastases to prevent cancer recurrence and progression after primary tumour therapy. RhoVac® was founded as a private company in Denmark 2007. In the following years the first steps in ter...
    RhoVac® is a pharmaceutical company dedicated to immuno-oncology, signifying that the body’s own immune system is stimulated to identify and destroy cancer cells. The primary focus of RhoVac® is to develop a cancer therapy that targets metastases to prevent cancer recurrence and progression after primary tumour therapy. RhoVac® was founded as a private company in Denmark 2007. In the following years the first steps in terms of development of the drug candidate, RV001, were taken. In 2015 the Swedish RhoVac AB, now headquarters, was founded, and in 2016 the company was listed at “Spotlight Stock Market”.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RhoVac ABSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Medicon Village AB, SE-223 81 Lund
    Telephone
    Telephone
    +46 73-751 72 78
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.rhovac.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/rhovac-aps
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rhovac board member resigns due to health reasons
    Rhovac board member resigns due to health reasons

    18 Oct 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/rhovac-board-member-resigns-due-to-health-reasons-301652079.html

    PRNEWSWIRE
    18 Oct 2022
    Share Share
    RhoVac’s Phase IIb prostate cancer trial fails to meet primary endpoint
    RhoVac’s Phase IIb prostate cancer trial fails to meet primary endpoint

    30 May 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/rhovac-prostate-cancer-trial/

    CLINICALTRIALSARENA
    30 May 2022
    Share Share
    RhoVac AB announces Database Lock in clinical phase IIb trial of onilcamotide
    RhoVac AB announces Database Lock in clinical phase IIb trial of onilcamotide

    10 May 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/rhovac-ab-announces-database-lock-in-its-clinical-phase-iib-trial-of-onilcamotide-301544454.html

    PRNEWSWIRE
    10 May 2022
    Share Share
    Interim safety review of RhoVac's clinical phase IIb study in prostate cancer
    Interim safety review of RhoVac's clinical phase IIb study in prostate cancer

    09 Dec 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/another-clean-interim-safety-review-of-rhovacs-clinical-phase-iib-study-in-prostate-cancer-301440945.html

    PRNEWSWIRE
    09 Dec 2021
    Share Share
    RhoVac presents 3-year follow-up results of the phI/II study in prostate cancer
    RhoVac presents 3-year follow-up results of the phI/II study in prostate cancer

    05 Oct 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/rhovac-presents-3-year-follow-up-results-of-the-phase-iii-study-in-prostate-cancer-301392659.html

    PRNEWSWIRE
    05 Oct 2021
    Share Share
    Clean interim safety review of RhoVac's clinical phase IIb study
    Clean interim safety review of RhoVac's clinical phase IIb study

    09 Jul 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/clean-interim-safety-review-of-rhovacs-clinical-phase-iib-study-in-prostate-cancer-301328656.html

    PRNEWSWIRE
    09 Jul 2021
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search